Reviewing the wonderful science at the IASLC 2024 Targeted Therapies of Lung Cancer poster session
Congratulations to Sen lab postdoc Dr. Subhamoy Chakraborty for receiving the AACR Margaret Foti Scholar-in-Training Award for his abstract submitted at the AACR Annual Meeting 2024
Dr. Triparna Sen is invited as poster mentor at the IASLC 2024 Targeted Therapies of Lung Cancer Meeting
Diving Into a Multifaceted Enzyme Pivotal to Understanding Lung Cancer
International Lung Cancer Survivorship Conference. Speaker: Histological Transformation of NSCLC into SCLC
Dr. Triparna Sen’s Lab: Pioneering Lung Cancer Research for a Better Tomorrow.
Dr. Triparna Sen is a Face of Change for Lung Cancer Research.
NSCLC transformation to SCLC. Facebook Live
How a Small Cell Lung Cancer Patient is Outliving the Odds
Investment in grants change the future for lung cancer patients
Lung Cancer Foundation of America. Hope with Answers Living with Lung Cancer: Title: Disparities in lung cancer
Lung Cancer Foundation of America. Hope with Answers Living with Lung Cancer, Episode-10 – Women in Science: The Young Investigators on the Front Lines in the Fight Against Lung Cancer
What would you tell young girls about entering the field of lung cancer research?
Good Morning America segment highlights need for lung cancer research
A young cancer researcher made a big splash when she discovered that inhibiting DNA damage response proteins sensitizes treatment-resistant lung cancer cells to immunotherapy
Scientist Honored for Discovering a Weakness in Aggressive Lung Cancer
MSK Scientists Reveal Biology of Shape-Shifting Lung Cancer
MSK Leaders Recognized in the 40 Under 40 in Cancer Class of 2020
Unexpected Finding Reveals New Target for Aggressive Form of Lung Cancer
Ferroptosis regulator as a novel therapeutic target for STK11/KEAP1 co-mutant lung adenocarcinoma
Women in Science Celebration: Interview with Dr Triparna Sen
The biology and therapeutic options for STK11/KEAP1 co-mutant lung adenocarcinoma
Improving small cell lung cancer life expectancy
Co-Mutation Points to New Target for Aggressive Form of Lung Cancer
Surprising discovery reveals new target for aggressive lung adenocarcinoma
Recipient of 2020 Lung cancer Foundation of America-Bristol-Myers-Squibb/International Research Award in Translational Immuno-oncology
Two young Investigators awarded $200,000 grants to make immunotherapy more effective for lung cancer patients
Efficacy and immune correlates of the SRA737 plus LDG regimen combination with anti-PD-L1 in an SCLC model
Novel immunotherapy approaches for small cell lung cancer
Small cell lung cancer may respond to the combination of immunotherapy and DNA damage repair inhibitors
Contact Us
Principal Investigator
Triparna Sen, PhD
Associate Professor
Co-Director, Lung Cancer PDX Program
E-mail
triparna.sen@mssm.edu
Lab Address
Icahn School of Medicine at Mount Sinai
1425 Madison Avenue, 15th Floor
New York, NY 10029
United States
Office Address
1425 Madison Avenue, 15th Floor
New York, NY 10029
United States